Igenomix  

Miami,  FL 
United States
http://www.igenomix.com
  • Booth: 333

IGENOMIX is a biotechnology company that provides advanced services in Reproductive Genetics. Our experience and advanced research capabilities have made this company one of the world leaders in its field, enabling it to provide effective solutions tailored to different infertility problems. IGENOMIX has lab operations in Miami, Los Angeles and New York, and 21 other laboratory affiliates around the world.

 Products

  • PGT-A
    PGT-A is a genetic test performed on embryos to identify numerical chromosomal abnormalities (aneuploidy)....

    • PGT-A is a genetic test performed on embryos to identify numerical chromosomal abnormalities (aneuploidy). By analysing all embryos generated in an IVF treatment cycle, those free of chromosomal aneuploidy can be selectively transferred. As a result, the pregnancy rates per transfer are significantly increased and the miscarriage rates decreased. Igenomix uses an advanced bioinformatics algorithm developed in-house using 100,000 embryo samples to provide accurate results.
  • EndomeTRIO
    The only one of its kind! EndomeTRIO is made up of three tests. ERA ( Endometrial Receptivity Analysis) EMMA (Endometrial Microbiome Metagenomic Analysis) and ALICE (Analysis of Infectious Chronic Endometritis)....

    • The only one of its kind!  EndomeTRIO is made up of three tests. ERA ( Endometrial Receptivity Analysis) EMMA (Endometrial Microbiome Metagenomic Analysis) and ALICE (Analysis of Infectious Chronic Endometritis). ERA evaluates endometrial receptivity and determines the optimal moment for embryo transfer. EMMA analyzes the microbiome for a better reproductive prognosis. ALICE detects the bacteria causing chronic endometritis and recommends the adequate treatment. 
  • ERA
    ERA® is the first diagnostic test that determines each woman’s unique personalized embryo transfer timing, therefore synchronizing the embryo transfer with the individualized window of implantation....

    • ERA® is the first diagnostic test that determines each woman’s unique personalized embryo transfer timing, therefore synchronizing the embryo transfer with the individualized window of implantation. The ERA utilizes RNA obtained from an endometrial tissue sample. The RNA analyzed and then classified by our ERA predictor as receptive or non-receptive, depending on the expression profile of the RNA. If the endometrium is non-receptive, the test enables us to find a personalized window of implantation for each patient in the majority of cases. 

Categories

Product Categories
  • Assisted Reproductive Technologies
  • Diagnostics
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Appointment Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined